AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
出版年份 2017 全文链接
标题
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
作者
关键词
Parkinson’s disease, α-synuclein, A53T mutation, Mouse model, Lewy-like pathology
出版物
Acta Neuropathologica Communications
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-02-01
DOI
10.1186/s40478-017-0416-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system
- (2015) Martina Böttner et al. BRAIN RESEARCH
- Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse
- (2015) Lian-Kun Song et al. PLoS One
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration
- (2013) Marusela Oliveras-Salvá et al. Molecular Neurodegeneration
- The Function of α-Synuclein
- (2013) Jacob T. Bendor et al. NEURON
- Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9
- (2011) A Van der Perren et al. GENE THERAPY
- Modelling of Parkinson's disease in mice
- (2011) Marie-Françoise Chesselet et al. LANCET NEUROLOGY
- Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
- (2011) James B. Koprich et al. PLoS One
- Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice
- (2010) Kunikazu Tanji et al. ACTA NEUROPATHOLOGICA
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
- (2010) James B Koprich et al. Molecular Neurodegeneration
- Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
- (2010) Shuwen Cao et al. Molecular Neurodegeneration
- Evaluation of α-synuclein immunohistochemical methods used by invited experts
- (2008) Thomas G. Beach et al. ACTA NEUROPATHOLOGICA
- Effects of UCH-L1 on α-synuclein over-expression mouse model of Parkinson’s disease
- (2008) Toru Yasuda et al. JOURNAL OF NEUROCHEMISTRY
- Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
- (2008) Shaji Theodore et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started